An Unusual Presentation Of Steven-Johnson Syndrome After Bnt162b2 Covid-19 Vaccination.
J Ayub Med Coll Abbottabad
; 35(1): 180-181, 2023.
Article
in English
| MEDLINE | ID: covidwho-2275839
ABSTRACT
We present a 23-year-old white British male that presented to the Accident and Emergency Department, two weeks after the second dose of the BNT162b2 (BioNTech/Pfizer) vaccine. No similar use has been documented previously in literature. We report one potential complication of the Pfizer COVID-19 vaccine A known case of Stevens-Johnson syndrome (SJS) that occurred after the second dose of the Pfizer COVID-19 vaccine alone without exposure to any other drug. Despite a significantly severe adverse drug reaction, the patient demonstrated completed recovery. The risk of developing severe cutaneous drug reaction from subsequent COVID-19 vaccinations in these patients is still unclear and remains a dilemma to date.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Stevens-Johnson Syndrome
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Adult
/
Humans
/
Male
/
Young adult
Language:
English
Journal:
J Ayub Med Coll Abbottabad
Journal subject:
Medicine
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS